Patents Assigned to MILLIPEDE, INC.
-
Patent number: 10335275Abstract: Methods related to delivery of various heart valve implants are described. The implant may be delivered using an ultrasound imaging delivery system. The ultrasound imaging delivery system may be used to deliver a variety of different devices, including mitral valve reshaping devices, mitral valve replacement valves, and others. A deployment catheter carrying an implant having a tissue anchor is advanced to a deployment site in a heart. An imaging element is positioned adjacent the implant and a relationship between the tissue anchor and an anatomical landmark in the heart is visualized. The implant is then attached by driving the tissue anchor into tissue in the heart.Type: GrantFiled: September 29, 2016Date of Patent: July 2, 2019Assignee: MILLIPEDE, INC.Inventors: Randall Lashinski, Kristian Kristoffersen, Matthew Rust, Richard Glenn, Michael Lee, Patrick Macaulay
-
Patent number: 10321999Abstract: The present disclosure includes a device for reshaping a heart valve. The device may include a central ring about a central axis and a plurality of arms coupled to the central ring, each of the arms coupled to the central ring at a pivot point at a first end of the arm, the arm comprising an attachment feature at a second point along the arm, the pivot point configured to allow movement of the arm about the pivot point through a plane extending radially from the central axis through the arm. Additionally, the plurality of arms may be contractable and may be extendable such that the hooks extend beyond a dilated heart valve. The present disclosure also includes associated methods and systems.Type: GrantFiled: March 13, 2014Date of Patent: June 18, 2019Assignee: Millipede, Inc.Inventors: Richard Glenn, Kristian Kristoffersen, Richard Klein, Randall Lashinski
-
Patent number: 10258466Abstract: Features for a heart valve device are described. The device may include a frame with anchors configured to secure the device to tissue. The frame may include a flared end or skirt for additional securement of the implanted device. The device may include a seal such as a barrier and/or cuff for preventing leakage. The device may contract for endovascular delivery of the device to the heart and expand for securement within the heart, such as the within the native mitral valve annulus. The device may include a replacement valve. The valve may have leaflets configured to re-direct blood flow along a primary flow axis.Type: GrantFiled: December 1, 2017Date of Patent: April 16, 2019Assignee: Millipede, Inc.Inventors: Randall Lashinski, Matthew Rust, Patrick Macaulay, Richard Glenn
-
Patent number: 10136985Abstract: Disclosed are systems and methods relating to an implant configured for reshaping a mitral valve. The implant comprises a plurality of struts with anchors for tissue engagement. The implant is compressible to a first, reduced diameter for transluminal or transapical navigation and delivery to the left atrium of a heart. The implant may then expand to a second, enlarged diameter to embed its anchors to the tissue surrounding and/or including the mitral valve. The size and/or shape of the implant may then be adjusted, pulling mitral annulus tissue radially inwardly, and restrained in the adjusted configuration to improve mitral valve function.Type: GrantFiled: September 30, 2015Date of Patent: November 27, 2018Assignee: Millipede, Inc.Inventors: Randall Lashinski, Matthew Rust, Patrick Macaulay, Terry Wayne Daniels, Kris Kristoffersen
-
Patent number: 9913706Abstract: Excessive dilation of the annulus of a mitral valve may lead to regurgitation of blood during ventricular contraction. This regurgitation may lead to a reduction in cardiac output. Disclosed are systems and methods relating to an implant configured for reshaping a mitral valve. The implant comprises a plurality of struts with anchors for tissue engagement. The implant is compressible to a first, reduced diameter for transluminal navigation and delivery to the left atrium of a heart. The implant may then expand to a second, enlarged diameter to embed its anchors to the tissue surrounding and/or including the mitral valve. The implant may then contract to a third, intermediate diameter, pulling the tissue radially inwardly, thereby reducing the mitral valve and lessening any of the associated symptoms including mitral regurgitation.Type: GrantFiled: August 29, 2017Date of Patent: March 13, 2018Assignee: Millipede, Inc.Inventors: Randall Lashinski, Matthew Rust, Patrick Macaulay, Terry Wayne Daniels, Kris Kristoffersen
-
Patent number: 9848983Abstract: Features for a heart valve device are described. The device may include a frame with anchors configured to secure the device to tissue. The frame may include a flared end or skirt for additional securement of the implanted device. The device may include a seal such as a barrier and/or cuff for preventing leakage. The device may contract for endovascular delivery of the device to the heart and expand for securement within the heart, such as the within the native mitral valve annulus. The device may include a replacement valve. The valve may have leaflets configured to re-direct blood flow along a primary flow axis.Type: GrantFiled: February 12, 2016Date of Patent: December 26, 2017Assignee: Millipede, Inc.Inventors: Randall Lashinski, Matthew Rust, Patrick Macaulay, Richard Glenn
-
Patent number: 9795480Abstract: Among other things, a tool to attach a support to a heart valve annulus includes a stabilizing body that includes features to stabilize an axial position of the tool relative to the annulus, and an attachment device connected to the stabilizing body, the stabilizing body and the attachment device being movable relative to one another under control from a location remote from the tool. The support may have an expandable tubular body having a plurality of struts, a plurality of tissue anchors extending from distally facing apexes in a distal direction post-deployment, wherein axial distal advance of the implantable annulus support causes the plurality of tissue anchors to axially engage tissue, and the implantable annulus support is self-contractible from a radially enlarged engagement configuration for engaging tissue of the mitral valve annulus, to a reduced, deployed configuration for modifying mitral valve annulus geometry.Type: GrantFiled: December 11, 2014Date of Patent: October 24, 2017Assignee: Millipede, Inc.Inventors: Steven F. Bolling, Jeremy A. Abbs, Brian A. Biancucci
-
Patent number: 9622862Abstract: Disclosed is an implantable mitral valve having an adjustable support. The support comprises a plurality of pairs of adjacent struts joined at apexes and a plurality of anchors for tissue engagement. The implant is adjustable to a first, reduced diameter for transluminal navigation and delivery to the left atrium of a heart. The implant may then expand to a second, enlarged diameter for the step of embedding the anchors into tissue surrounding and/or including the mitral valve. The implant may then be adjusted to a third, intermediate diameter, pulling the tissue radially inwardly, thereby reducing the native mitral valve annulus and supporting the prosthetic mitral valve.Type: GrantFiled: September 28, 2015Date of Patent: April 18, 2017Assignee: Millipede, Inc.Inventors: Randall Lashinski, Matthew Rust, Patrick Macaulay, Terry Wayne Daniels, Kris Kristoffersen
-
Patent number: 9615926Abstract: Excessive dilation of the annulus of a mitral valve may lead to regurgitation of blood during ventricular contraction. This regurgitation may lead to a reduction in cardiac output. Disclosed are systems and methods relating to an implant configured for reshaping a mitral valve. The implant comprises a plurality of struts with anchors for tissue engagement. The implant is compressible to a first, reduced diameter for transluminal navigation and delivery to the left atrium of a heart. The implant may then expand to a second, enlarged diameter to embed its anchors to the tissue surrounding and/or including the mitral valve. The implant may then contract to a third, intermediate diameter, pulling the tissue radially inwardly, thereby reducing the mitral valve and lessening any of the associated symptoms including mitral regurgitation.Type: GrantFiled: September 22, 2015Date of Patent: April 11, 2017Assignee: Millipede, Inc.Inventors: Randall Lashinski, Matthew Rust, Patrick Macaulay, Terry Wayne Daniels, Kris Kristoffersen
-
Patent number: 9610156Abstract: Systems, devices and methods for heart valve prostheses are described. An implant is inserted proximate a mitral valve, and has a tubular body and a plurality of piercing members, the tubular body comprising an upper diameter and a lower diameter. Tissue proximate the mitral valve is engaged by the plurality of piercing members and the tubular body transitions from a first structural configuration to a second structural configuration by application of an expansive force to the tubular body proximate the upper diameter, the first structural configuration having the upper diameter smaller than the lower diameter and the second structural configuration having the upper diameter larger than the lower diameter.Type: GrantFiled: September 13, 2013Date of Patent: April 4, 2017Assignee: Millipede, Inc.Inventor: Randall Lashinski
-
Patent number: 9192471Abstract: In general, in an aspect, an annulus of a heart valve is caused to dilate to a predetermined configuration by pushing a delivery tool distally through the annulus from one heart chamber to another heart chamber. A valve support is attached to the delivery tool. The valve support has a plurality of barbs or hooks attached thereon. While the annulus is dilated, the valve support is attached to tissue at locations along the annulus by attaching the barbs or hooks to the tissue. After attachment, the support is caused to contract.Type: GrantFiled: January 8, 2007Date of Patent: November 24, 2015Assignee: MILLIPEDE, INC.Inventor: Steven F. Bolling
-
Patent number: 9180005Abstract: Excessive dilation of the annulus of a mitral valve may lead to regurgitation of blood during ventricular contraction. This regurgitation may lead to a reduction in cardiac output. Disclosed are systems and methods relating to an implant configured for reshaping a mitral valve. The implant comprises a plurality of struts with anchors for tissue engagement. The implant is compressible to a first, reduced diameter for transluminal navigation and delivery to the left atrium of a heart. The implant may then expand to a second, enlarged diameter to embed its anchors to the tissue surrounding and/or including the mitral valve. The implant may then contract to a third, intermediate diameter, pulling the tissue radially inwardly, thereby reducing the mitral valve and lessening any of the associated symptoms including mitral regurgitation.Type: GrantFiled: December 5, 2014Date of Patent: November 10, 2015Assignee: MILLIPEDE, INC.Inventors: Randall Lashinski, Matthew Rust, Patrick Macaulay, Terry Wayne Daniels, Kris Kristoffersen